1. Reduced Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in Type 2 Diabetes Mellitus: Will Metformin Never Stop Its Pleasant Surprises?

   • Stella Papachristou
   • Djordje S. Popovic
   • Nikolaos Papanas

   Editorial 28 March 2022 Pages: 2283 - 2286

2. Proposal for a New Protocol for the Management of Immune Thrombocytopenia (ITP)

   • Tomás José González-López
   • Drew Provan

   Commentary 07 April 2022 Pages: 2287 - 2291

3. Clinical and Genetic Evaluation of People with or at Risk of Hereditary ATTR Amyloidosis: An Expert Opinion and Consensus on Best Practice in Ireland and the UK

   • Julian D. Gillmore
   • Mary M. Reilly
   • Philip N. Hawkins

   Commentary Open access 13 April 2022 Pages: 2292 - 2301

   

4. Quality Standard Position Statements for Health System Policy Changes in Diagnosis and Management of COPD: A Global Perspective

   • Mohit Bhutani
   • David B. Price
   • John R. Hurst

   Commentary Open access 28 April 2022 Pages: 2302 - 2322

   

5. Improving Care in Eosinophil-Associated Diseases: A Charter

   • David J. Jackson
   • Praveen Akuthota
   • Tonya Winders

   Commentary Open access 30 April 2022 Pages: 2323 - 2341

   

6. Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era

   • Stefan Schreiber
   • Shomron Ben-Horin
   • Walter Reinisch

   Review Open access 06 January 2022 Pages: 2342 - 2364

   

7. A Review of the Unique Drug Development Strategy of Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A First-in-Class, Once-Daily, Single-Inhaler, Fixed-Dose Combination Treatment for Asthma

   • Dominic Brittain
   • Peter D’Andrea
   • Hanns-Christian Tillmann

   Review Open access 24 January 2022 Pages: 2365 - 2378

   

8. The Selective Role of Open and Endoscopic Approaches for Sinonasal Malignant Tumours

   • Fernando López
   • Jatin P. Shah
   • Alfio Ferlito

   Review Open access 30 March 2022 Pages: 2379 - 2397

   

9. Advances in Clinical Cardiology 2021: A Summary of Key Clinical Trials

   • Patrick Savage
   • Brian Cox
   • Ian Menown

   Review Open access 28 April 2022 Pages: 2398 - 2437

   

10. Iron Deficiency in Women’s Health: New Insights into Diagnosis and Treatment

    • Christina M. Moisidis-Tesch
    • Lee P. Shulman

    Review 30 April 2022 Pages: 2438 - 2451

    

11. Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative Review

    • Mojca Jensterle
    • Manfredi Rizzo
    • Andrej Janež

    Review 03 May 2022 Pages: 2452 - 2467

    

12. Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational Study

    • Johan Dalén
    • Anushri Chitkara
    • Zaina P. Qureshi

    Original Research Open access 09 November 2021 Pages: 2468 - 2486

    

13. Correction to: Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational Study

    • Johan Dalén
    • Anushri Chitkara
    • Zaina P. Qureshi

    Publisher Correction 03 March 2022 Pages: 2487 - 2488

    

14. What Are Realistic Expectations to Become Free of Overactive Bladder Symptoms? Experience from Non-interventional Studies with Propiverine

    • A. Elif Müderrisoglu
    • Matthias Oelke
    • Martin C. Michel

    Original Research Open access 24 March 2022 Pages: 2489 - 2501

    

15. Epidemiology and Economic Burden of Atopic Dermatitis: Real-World Retrospective Data from a Large Nationwide Israeli Healthcare Provider Database

    • Clara Weil
    • Philip B. Sugerman
    • Yael A. Leshem

    Original Research Open access 29 March 2022 Pages: 2502 - 2514

    

16. Real-World Effectiveness of Sipuleucel-T on Overall Survival in Men with Advanced Prostate Cancer Treated with Androgen Receptor-Targeting Agents

    • Jason M. Hafron
    • Helen M. Wilfehrt
    • Rana R. McKay

    Original Research Open access 30 March 2022 Pages: 2515 - 2532

    

17. Occurrence and Prognosis of Secondary Lung Cancer in Patients with Primary Nasal Cavity and Sinus Squamous Cell Carcinoma

    • Jing Feng
    • Gang Jin
    • Xiang Song

    Original Research 31 March 2022 Pages: 2533 - 2543

    

18. Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer

    • Daniel Simmons
    • Stephanie V. Blank
    • Kimmie McLaurin

    Original Research Open access 01 April 2022 Pages: 2544 - 2561

    

19. Menstrual Symptoms, Health-Related Quality of Life, and Work Productivity in Japanese Women with Dysmenorrhea Receiving Different Treatments: Prospective Observational Study

    • Osamu Yoshino
    • Noriko Takahashi
    • Yoshimi Suzukamo

    Original Research Open access 01 April 2022 Pages: 2562 - 2577

    

20. Treatment Patterns Among Patients with Bipolar Disorder in the United States: A Retrospective Claims Database Analysis

    • Rakesh Jain
    • Amanda M. Kong
    • Amanda Harrington

    Original Research Open access 06 April 2022 Pages: 2578 - 2595

    

21. Real-World Data Analysis of Second-Line Antiangiogenic Targeted Treatments Following Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies and First-Line FOLFOX for Patients with Metastatic Colorectal Cancer

    • Hironaga Satake
    • Yoshinori Kagawa
    • Akitaka Makiyama

    Original Research Open access 06 April 2022 Pages: 2596 - 2613

    

22. Pembrolizumab Plus Chemotherapy as First-Line Treatment for Advanced Esophageal Cancer: A Cost-Effectiveness Analysis

    • Youwen Zhu
    • Kun Liu
    • Libo Peng

    Original Research 08 April 2022 Pages: 2614 - 2629

    

23. Real-World Treatment Patterns After CD19-Directed CAR T Cell Therapy Among Patients with Diffuse Large B Cell Lymphoma

    • Jessica J. Jalbert
    • Ning Wu
    • Jon E. Arnason

    Original Research Open access 09 April 2022 Pages: 2630 - 2640

    

24. Enzalutamide in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Asian Multiregional, Randomized Study

    • Yeong-Shiau Pu
    • Hanjong Ahn
    • Li-Ping Xie

    Original Research Open access 10 April 2022 Pages: 2641 - 2656

    

25. Treatment Goals for Psoriasis as Measured by Patient Benefit Index: Results of a National Psoriasis Foundation Survey

    • April Armstrong
    • Emily Edson-Heredia
    • Stacy Smith

    Original Research Open access 11 April 2022 Pages: 2657 - 2667

    

26. Tafasitamab Plus Lenalidomide Versus 3 Rituximab-Based Treatments for Non-Transplant Eligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Matching-Adjusted Indirect Comparison

    • Raul Cordoba
    • Thibaud Prawitz
    • Lorenzo Sabatelli

    Original Research Open access 11 April 2022 Pages: 2668 - 2687

    

27. Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM

    • Yuji Kawaguchi
    • Shoko Miyamoto
    • Yasuro Kumeda

    Original Research Open access 11 April 2022 Pages: 2688 - 2700

    

28. Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial

    • Justus G. Garweg
    • Jana Štefanickova
    • the VIOLET Investigators

    Original Research Open access 12 April 2022 Pages: 2701 - 2716

    

29. Cost-Effectiveness of Treating Patients with Chronic Kidney Disease and Prior Hyperkalemia with Renin–Angiotensin–Aldosterone System Inhibitor and Patiromer: A Swiss Public Healthcare Perspective

    • Barbara Fischer
    • Andreas Serra
    • Harry Telser

    Original Research Open access 13 April 2022 Pages: 2717 - 2730

    

30. Observational Study in a Real-World Setting of Targeted Therapy in the Systemic Treatment of Progressive Unresectable or Metastatic Well-Differentiated Pancreatic Neuroendocrine Tumors (pNETs) in France: OPALINE Study

    • Denis Smith
    • Côme Lepage
    • Catherine Lombard-Bohas

    Original Research Open access 13 April 2022 Pages: 2731 - 2748

    

31. Adherence to Subcutaneous Interferon Beta-1a in Multiple Sclerosis Patients Receiving Periodic Feedback on Drug Use by Discussion of Readouts of Their Rebismart^® Injector: Results of the Prospective Cohort Study REBIFLECT

    • Peter Rieckmann
    • Tjalf Ziemssen
    • Uwe K. Zettl

    Original Research Open access 15 April 2022 Pages: 2749 - 2760

32. Mesenchymal Stem Cell Therapy Awareness, Knowledge, and Use for the Treatment of Fistulizing Crohn’s Disease: An International Survey Among Gastroenterologists and Colorectal Surgeons

    • Paul Williams
    • Catherine Klersy
    • Rachele Ciccocioppo

    Original Research Open access 15 April 2022 Pages: 2761 - 2777

    

33. Association Between Granulocyte Colony-Stimulating Factor (G-CSF) Use and Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Among Elderly Patients with Breast, Lung, or Prostate Cancer

    • Mark D. Danese
    • Jennifer Schenfeld
    • Gary Lyman

    Original Research 16 April 2022 Pages: 2778 - 2795

    

34. “I Can’t Take off My Shirt or Do My Own Hair”—A Qualitative Investigation of the Symptoms and Impact Experience of Children and Adolescents with Fibrodysplasia Ossificans Progressiva (FOP)

    • Jessica T. Markowitz
    • Diana Rofail
    • Patrick Marquis

    Original Research Open access 16 April 2022 Pages: 2796 - 2805

    

35. Baseline Characteristics and Treatment Response to Ixekizumab Categorised by Sex in Radiographic and Non-radiographic Axial Spondylarthritis Through 52 Weeks: Data from Three Phase III Randomised Controlled Trials

    • Irene E. van der Horst-Bruinsma
    • Kurt de Vlam
    • Marina Magrey

    Original Research Open access 16 April 2022 Pages: 2806 - 2819

    

36. Unmet Needs of Glycaemic Control and Risk Factors of Residual Hyperglycaemia in a Chinese Population with Type 2 Diabetes Initiating Basal Insulin: A Post Hoc Analysis of the FPG GOAL Study

    • Xin Wang
    • Guangyu Wu
    • Wenying Yang

    Original Research Open access 16 April 2022 Pages: 2820 - 2830

    

37. Analysis of a Real-World Progression Variable and Related Endpoints for Patients with Five Different Cancer Types

    • Aracelis Z. Torres
    • Nathan C. Nussbaum
    • Rebecca A. Miksad

    Original Research Open access 17 April 2022 Pages: 2831 - 2849

    

38. Use of Perindopril Arginine/Indapamide/Amlodipine in the Management of Hypertension in Two Sub-Saharan African Island Countries of Madagascar and Mauritius

    • Armand Mbanya
    • Azarkhan Ackbarkhan
    • Jean Claude Mbanya

    Original Research Open access 18 April 2022 Pages: 2850 - 2861

    

39. Ixekizumab Citrate-Free Formulation: Results from Two Clinical Trials

    • Sanjay Chabra
    • B. J. Gill
    • Luis Puig

    Original Research Open access 21 April 2022 Pages: 2862 - 2872

    

40. The Durable Safety and Effectiveness of Lixisenatide in Japanese People with Type 2 Diabetes: The Post-Marketing Surveillance PRANDIAL Study

    • Yasuo Terauchi
    • Makiko Usami
    • Tomoyuki Inoue

    Original Research Open access 21 April 2022 Pages: 2873 - 2888

    

41. Inflammatory Bowel Disease Patients’ Treatment Preferences Using a Discrete Choice Experiment Technique: The InPuT Study

    • Stefan Schubert
    • Nils Picker
    • Wolfgang Mohl

    Original Research Open access 22 April 2022 Pages: 2889 - 2905

    

42. Disease Progression Stages and Burden in Patients with Duchenne Muscular Dystrophy Using Administrative Claims Supplemented by Electronic Medical Records

    • Joel Iff
    • Yi Zhong
    • CINRG DNHS Investigators

    Original Research 23 April 2022 Pages: 2906 - 2919

43. Clinicopathologic Characteristics and Prognosis of PDGFRA-Mutant Gastrointestinal Stromal Tumors: A Large-Scale, Multi-Institutional, Observational Study in China

    • Peng Zhang
    • Ming Wang
    • Kaixiong Tao

    Original Research 24 April 2022 Pages: 2920 - 2931

    

44. Early Real-World Experience of Tofacitinib for Psoriatic Arthritis: Data from a United States Healthcare Claims Database

    • Philip J. Mease
    • Pamela Young
    • Arthur Kavanaugh

    Original Research Open access 28 April 2022 Pages: 2932 - 2945

    

45. High Expression of C8orf76 Is an Independent Predictive Factor of Poor Prognosis in Patients with Breast Cancer

    • Yitong Wang
    • Xiaoshen Dong

    Original Research 28 April 2022 Pages: 2946 - 2960

    

46. 17-Year Follow-up of Comparing Mastoscopic and Conventional Axillary Dissection in Breast Cancer: A Multicenter, Randomized Controlled Trial

    • Chengyu Luo
    • Changsheng Wei
    • Yun Yang

    Original Research 29 April 2022 Pages: 2961 - 2970

    

47. Cost-Effectiveness of Linaclotide Compared to Osmotic Laxatives in the Treatment of Irritable Bowel Syndrome with Constipation in China

    • Dunming Xiao
    • Yue Zhang
    • Yingyao Chen

    Original Research 30 April 2022 Pages: 2971 - 2983

    

48. Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in the ALTAIR Study: 96-Week Outcomes in the Polypoidal Choroidal Vasculopathy Subgroup

    • Annabelle A. Okada
    • Kanji Takahashi
    • The ALTAIR Study Investigators

    Original Research Open access 03 May 2022 Pages: 2984 - 2998

    

49. Changes in Refractive Error Under COVID-19: A 3-Year Follow-up Study

    • Xiaoyan Yang
    • Qian Fan
    • Yan Wang

    Original Research Open access 04 May 2022 Pages: 2999 - 3010

    

50. Efficacy and Safety of ELOM-080 as Add-On Therapy in COVID-19 Patients with Acute Respiratory Insufficiency: Exploratory Data from the Prospective Placebo-Controlled COVARI Trial

    • Michael Dreher
    • Christian Grohè
    • Stephan Eisenmann

    Brief Report Open access 13 April 2022 Pages: 3011 - 3018